Rigel Pharmaceuticals (RIGL) Retained Earnings (2010 - 2026)
Rigel Pharmaceuticals (RIGL) posted quarterly Retained Earnings of -$128000.0 for Q1 2026, down 6300.0% year-over-year from $2064.5 in Q1 2025, and up 99.99% quarter-over-quarter from -$1.0 billion in Q4 2025.
Rigel Pharmaceuticals (RIGL) Retained Earnings (2010 - 2026) Analysis & Trends
Rigel Pharmaceuticals' Retained Earnings history runs 17 years deep, the most recent figure standing at -$128000.0 for Q1 2026.
- In Q1 2026, Retained Earnings fell 6300.0% year-over-year to -$128000.0; the TTM figure through Mar 2026 stood at -$128000.0 (down 6300.0% YoY), while the FY2025 annual figure was -$1.0 billion, down 10230510.0% from the prior year.
- Retained Earnings for Q1 2026 stood at -$128000.0, up from -$1.0 billion in the prior quarter.
- The five-year high for Retained Earnings was $10000.0 in Q4 2024, with the low at -$1.4 billion in Q2 2024.
- The 5-year median for Retained Earnings is -$1.0 billion (2025), against an average of -$709.0 million.
- The sharpest annual moves came in 2022 and 2023: Retained Earnings slumped 17298350.0% in 2022, then soared 105.23% in 2023.
- Rigel Pharmaceuticals' Retained Earnings stood at -$153000.0 in 2022, then surged by 105.23% to $8000.0 in 2023, then climbed by 25.0% to $10000.0 in 2024, then slumped by 10230510.0% to -$1.0 billion in 2025, then surged by 99.99% to -$128000.0 in 2026.
- Business Quant data shows RIGL's Retained Earnings at -$128000.0 in Q1 2026, -$1.0 billion in Q4 2025, and -$1.3 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -4.00 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 13.05 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -104.13 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 4.38 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -6.33 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.57 Bn |
| 10 | Rigel Pharmaceuticals | 795.39 Mn | 700.06 Mn | 70.18 Mn | -997.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -997.10 Mn |
| Mar 31, 2026 | -128,000.00 |
| Dec 31, 2025 | -1.02 Bn |
| Sep 30, 2025 | -1.29 Bn |
| Jun 30, 2025 | -1.32 Bn |
| Mar 31, 2025 | -2,000.00 |
| Dec 31, 2024 | 10,000.00 |
| Sep 30, 2024 | -1.40 Bn |
| Jun 30, 2024 | -1.42 Bn |
| Mar 31, 2024 | -1.42 Bn |
| Dec 31, 2023 | 8,000.00 |
| Sep 30, 2023 | -15,000.00 |
| Jun 30, 2023 | -1.40 Bn |
| Mar 31, 2023 | -1.40 Bn |
| Dec 31, 2022 | -153,000.00 |
| Sep 30, 2022 | -1.38 Bn |
| Jun 30, 2022 | -438,000.00 |
| Mar 31, 2022 | -416,000.00 |
| Dec 31, 2021 | -1.32 Bn |
| Sep 30, 2021 | 8,000.00 |